Trial Details

COMPLETED
Basic Information
Clinical ID c3406
Identifier NCT02107196
Trial Title 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Irritable Bowel Syndrome With Diarrhea
Interventions DRUG: Ibodutant 10 mg|DRUG: Placebo
Participant Information
Sponsor Menarini Group
City Huntsville
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2014-03
Primary Completion Date 2015-06
Completion Date 2015-06